Share on StockTwits

Sigma-Aldrich (NASDAQ:SIAL) has been given an average recommendation of “Hold” by the ten analysts that are covering the company, StockRatingsNetwork.com reports. Two investment analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $92.33.

Shares of Sigma-Aldrich (NASDAQ:SIAL) traded down 0.68% on Wednesday, hitting $103.16. The stock had a trading volume of 56,648 shares. Sigma-Aldrich has a 1-year low of $81.86 and a 1-year high of $104.32. The stock’s 50-day moving average is $102.4 and its 200-day moving average is $97.8. The company has a market cap of $12.273 billion and a P/E ratio of 24.56.

Sigma-Aldrich (NASDAQ:SIAL) last posted its quarterly earnings results on Thursday, July 24th. The company reported $1.11 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.11. The company had revenue of $701.00 million for the quarter, compared to the consensus estimate of $706.14 million. During the same quarter last year, the company posted $1.05 earnings per share. Sigma-Aldrich’s revenue was up 2.9% compared to the same quarter last year. Analysts expect that Sigma-Aldrich will post $4.36 EPS for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Sigma-Aldrich in a research note on Tuesday, August 12th. They now have a $107.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Sigma-Aldrich in a research note on Friday, July 25th. They now have a $97.00 price target on the stock, up previously from $95.00. Finally, analysts at Citigroup Inc. initiated coverage on shares of Sigma-Aldrich in a research note on Thursday, July 17th. They set a “neutral” rating and a $107.00 price target on the stock.

Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes the range of chemicals, biochemicals and equipment available globally and also provides global biopharmaceutical testing services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.